ICRA

20 per cent growth in FY2022 revenues expected, expected to go slow on capex to conserve cash and focus on better utilisation of…

Profitability margin is likely to be hit hard because of both revenue and cost pressures                       

Revenues are expected to decline by over 50 per cent; high operating leverage inherent in hospital business, coupled with sharp…

The revenues from international patients are likely to completely dry up, due to visa cancellations and will continue to be…

The strong performance of the sector is in line with our expectations: Icra

Tough days were triggered on account of several regulatory measures, including cap on prices of stents by National Pharmaceutical…

Transactions in hospital sector FY2019 amounted to Rs 7615 crore, as against transactions worth Rs 2991 crore done in FY2018

The performance of healthcare companies bottomed out, will witness improvement over medium term